ChemWerth entered a manufacturing partnership with Tianjin Tianyao Pharmaceuticals Co., Ltd., a China-based manufacturer and exporter of corticosteroid products. Tianjin Tianyao Pharmaceuticals is chair to the Chinese state steroid hormone association and is the first to authenticate cGMP for production of corticosteroid APIs in China. The company has been recognized for its technical and research capabilities, and has a portfolio of more than 40 new technologies and products. Through the partnership, the two can now offer customers a new line of hormonal API products.

“The significant resources of Tianjin Tianyao Pharmaceuticals adds much to our existing competencies in generic APIs,” said Peter Werth, chief executive officer and chairman of ChemWerth, Inc. “Given ChemWerth’s successful track record, robust new product development capacity and superior cGMP regulatory resources, we believe our customers will benefit greatly from this new partnership,” he added.